Skip to content
MarketScale
‹ Back to IndustriesHealthcare

What a New Look for HIPAA Means for Physicians

No industry looks the same after more than a quarter century of innovation and breakthroughs. Yet in the medical world, HIPAA, a bill passed by the U.S. Congress in 1996, has remained a key regulatory guideline. With innovations in the healthcare sector occurring at a rapid rate, this bill may finally be getting long overdue…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

No industry looks the same after more than a quarter century of innovation and breakthroughs. Yet in the medical world, HIPAA, a bill passed by the U.S. Congress in 1996, has remained a key regulatory guideline. With innovations in the healthcare sector occurring at a rapid rate, this bill may finally be getting long overdue tweaks.

For the first time since 2013, several proposals have been made to change the legislation for 2019.

Changes to Look For

Physicians need to be aware of these updates and how they will affect their practices. All offices will be required to implement these three small modifications into their HIPAA processes:

  • Patients are now able to request digital medical records through digital formats. The clinic will have 30 days, whether on paper or digitally, to produce the information.
  • Patients who pay for services personally and in full may require that the clinic not share treatment information with the patient’s health plan.
  • Clinics can provide immunization information to schools if they are required by law to have it and if a parent/guardian gives written permission.

Other changes include a rise in the maximum penalty for non-compliance to a $50,000 limit, an increase in restrictions on receiving patient authorization to use personal information on marketing campaigns, the simplification of patient authorization for health data for research, and the elimination of insurance companies’ use of genetic information for coverage and cost determinations.

When to Expect Change to Come

A somewhat laborious process, changes to HIPAA regulations follow a specific path. First, the Department of Health and Human Services (HHS) seeks feedback on HIPAA regulations to see which areas are problematic or outdated. After careful consideration of the feedback, the HHS submits a notice of proposed rule changes and queries healthcare industry stakeholders for comments on the suggested modifications. Once feedback and comments have been carefully assimilated, a final rule change is established. At that time, a temporary grace period will begin so that practices can prepare for compliance with the new regulations. That said, it is possible that changes made to HIPAA this year will not be implemented until 2020.

What This Means for Physicians

While these new rules have not been formalized as of yet, they will have a noticeable impact on the day-to-day routines of physicians around the country. Most notably, the decreased tolerance of non-compliance from the government will assure that clinics follow procedure. HIPAA has been in place in various forms for 23 years, so clinics should already be comfortable working within the parameters of the bill. Fortunately, the grace period will give practices the necessary time to rework their daily procedures to incorporate imminent regulatory changes and avoid non-compliance.

ChartLogic believes education about the latest industry changes is critical, not only to business success, but to patient-physician relationships. To read more about the impact of new HIPAA rules, click here.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512